World Asset Management’s Largest Healthcare Stock Positions in $316 Million Portfolio

We’ve researched and uncovered World Asset Management’s top holdings in the Healthcare sector for the quarter ending September 30th, 2011. The firm held 137 stocks in the Healthcare sector at the end of the quarter with an aggregate market value of $316.782 million.

Johnson & Johnson (NYSE:JNJ): On 06/30/2011, World Asset Management reported holding 584,645 shares with a market value of $38,890,583. This comprised 0.76% of the total portfolio. On 09/30/2011, World Asset Management reported holding 525,145 shares with a market value of $33,446,484. This comprised 0.87% of the total portfolio. The net change in shares for this position over the two quarters is -59,500. About Company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.

Pfizer Inc. (NYSE:PFE): On 06/30/2011, World Asset Management reported holding 1,571,536 shares with a market value of $32,373,642. This comprised 0.63% of the total portfolio. On 09/30/2011, World Asset Management reported holding 1,370,368 shares with a market value of $24,228,107. This comprised 0.63% of the total portfolio. The net change in shares for this position over the two quarters is -201,168. About Company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.

Novartis Ag (NYSE:NVS): On 06/30/2011, World Asset Management reported holding 368,835 shares with a market value of $22,539,507. This comprised 0.44% of the total portfolio. On 09/30/2011, World Asset Management reported holding 350,038 shares with a market value of $19,521,619. This comprised 0.51% of the total portfolio. The net change in shares for this position over the two quarters is -18,797. About Company: Novartis AG manufactures pharmaceutical and consumer healthcare products. The Company produces pharmaceuticals for cardiovascular, respiratory and infectious diseases; oncology, neuroscience, transplantation, dermatology, gastrointestinal and urinary conditions, and arthritis; vaccines and diagnostics; vision, and animal health products.

Merck & Co. Inc. (NYSE:MRK): On 06/30/2011, World Asset Management reported holding 610,874 shares with a market value of $21,557,744. This comprised 0.42% of the total portfolio. On 09/30/2011, World Asset Management reported holding 544,873 shares with a market value of $17,817,348. This comprised 0.46% of the total portfolio. The net change in shares for this position over the two quarters is -66,001. About Company: Merck & Co., Inc. is a global pharmaceutical company that discovers, develops, manufactures, and markets a broad range of human and animal health products. Merck’s products include a treatment for elevated cholesterol, a treatment for male pattern hair loss, a preventive treatment for osteoporosis, a treatment for hypertension, and a treatment for allergic rhinitis.

Abbott Laboratories (NYSE:ABT): On 06/30/2011, World Asset Management reported holding 330,056 shares with a market value of $17,367,546. This comprised 0.34% of the total portfolio. On 09/30/2011, World Asset Management reported holding 298,241 shares with a market value of $15,252,045. This comprised 0.4% of the total portfolio. The net change in shares for this position over the two quarters is -31,815. About Company: Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company’s products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.

Glaxosmithkline Plc (NYSE:GSK): On 06/30/2011, World Asset Management reported holding 349,235 shares with a market value of $14,982,182. This comprised 0.29% of the total portfolio. On 09/30/2011, World Asset Management reported holding 322,310 shares with a market value of $13,308,180. This comprised 0.35% of the total portfolio. The net change in shares for this position over the two quarters is -26,925. About Company: GlaxoSmithKline plc is a research-based pharmaceutical group that develops, manufactures and markets vaccines, prescription and over-the-counter medicines, as well as health-related consumer products. The Group, which also provides laboratory testing and disease management services, specializes in treatments for respiratory, central nervous system, gastro-intestinal and genetic disorders

Bristol-myers Squibb Company (NYSE:BMY): On 06/30/2011, World Asset Management reported holding 370,559 shares with a market value of $10,731,388. This comprised 0.21% of the total portfolio. On 09/30/2011, World Asset Management reported holding 332,121 shares with a market value of $10,421,957. This comprised 0.27% of the total portfolio. The net change in shares for this position over the two quarters is -38,438. About Company: Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, manufactures and sells pharmaceutical and nutritional products. The Company’s products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders.

Amgen Inc. (NASDAQ:AMGN): On 06/30/2011, World Asset Management reported holding 214,417 shares with a market value of $12,511,232. This comprised 0.25% of the total portfolio. On 09/30/2011, World Asset Management reported holding 182,115 shares with a market value of $10,009,040. This comprised 0.26% of the total portfolio. The net change in shares for this position over the two quarters is -32,302. About Company: Amgen Inc. discovers, develops, manufactures, and markets human therapeutics based on cellular and molecular biology. The Company focuses its research on secreted protein and small molecule therapeutics, with particular emphasis on neuroscience and cancer. Amgen concentrates on the areas of hematology, cancer, infectious disease, endocrinology, neurobiology, and inflammation.

Unitedhealth Group Inc. (NYSE:UNH): On 06/30/2011, World Asset Management reported holding 233,099 shares with a market value of $12,023,247. This comprised 0.24% of the total portfolio. On 09/30/2011, World Asset Management reported holding 206,282 shares with a market value of $9,513,726. This comprised 0.25% of the total portfolio. The net change in shares for this position over the two quarters is -26,817. About Company: UnitedHealth Group Incorporated owns and manages organized health systems in the United States and internationally. The Company provides employers products and resources to plan and administer employee benefit programs. UnitedHealth also serves the health needs of older Americans, provides specialized care services, and provides health care information and research to providers and payers.

Sanofi-aventis (NYSE:SNY): On 06/30/2011, World Asset Management reported holding 262,090 shares with a market value of $10,528,155. This comprised 0.21% of the total portfolio. On 09/30/2011, World Asset Management reported holding 254,441 shares with a market value of $8,345,665. This comprised 0.22% of the total portfolio. The net change in shares for this position over the two quarters is -7,649. About Company: Sanofi-Aventis is a global pharmaceutical company that researches, develops and manufactures prescription pharmaceuticals and vaccines. The Company develops cardiovascular, thrombosis, metabolic disorder, central nervous system, internal medicine and oncology drugs, and vaccines.

(Note: Data regarding World Asset Management’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More from The Cheat Sheet